{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:48:32Z","timestamp":1762955312338},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.semerg.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T22:00:36Z","timestamp":1407276036000},"page":"313-325","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recomendaci\u00f3n de la vacuna antineumoc\u00f3cica en las enfermedades respiratorias cr\u00f3nicas"],"prefix":"10.1016","volume":"40","author":[{"given":"F.","family":"Casas Maldonado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Alfageme Michavila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.S.","family":"Barchil\u00f3n Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.I.","family":"Peis Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Vargas Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2014.06.012_bib0005","series-title":"El control de las enfermedades transmisibles","first-page":"552","article-title":"Neumon\u00eda neumoc\u00f3cica","author":"Moore","year":"2011"},{"key":"10.1016\/j.semerg.2014.06.012_bib0010","first-page":"51","article-title":"Immune responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination","volume":"3","author":"Westerink","year":"2012","journal-title":"Aging Dis"},{"key":"10.1016\/j.semerg.2014.06.012_bib0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/thx.2010.143982","article-title":"Microbial aetiology of community-acquired pneumonia and its relation to severity","volume":"66","author":"Cill\u00f3niz","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.semerg.2014.06.012_bib0020","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: A systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semerg.2014.06.012_bib0025","first-page":"217","article-title":"Streptococcus pneumoniae: Epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.semerg.2014.06.012_bib0030","series-title":"La enfermedad neumoc\u00f3cica y su prevenci\u00f3n. Caminando hacia el futuro","first-page":"113","article-title":"Epidemiolog\u00eda de la enfermedad neumoc\u00f3cica en el adulto","author":"Salleras","year":"2010"},{"key":"10.1016\/j.semerg.2014.06.012_bib0035","series-title":"Presente y futuro de la vacunaci\u00f3n antineumoc\u00f3cica en el adulto","first-page":"211","article-title":"La enfermedad neumoc\u00f3cica y su prevenci\u00f3n. Caminando hacia el futuro","author":"Campins","year":"2010"},{"key":"10.1016\/j.semerg.2014.06.012_bib0040","series-title":"World Heart Repport 1999: Making a difference","year":"1999"},{"key":"10.1016\/j.semerg.2014.06.012_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0272-5231(05)70236-7","article-title":"Pneumonia in the elderly","volume":"20","author":"Feldman","year":"1999","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semerg.2014.06.012_bib0050","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.semerg.2014.06.012_bib0055","first-page":"373","article-title":"23-valent pneumococcal polysaccharide vaccine. WHO position paper","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.semerg.2014.06.012_bib0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semerg.2014.06.012_bib0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease among hospitalised patients in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.semerg.2014.06.012_bib0070","first-page":"232","article-title":"Consenso sobre la vacunaci\u00f3n anti-neumoc\u00f3cica en el adulto con patolog\u00eda de base","volume":"26","author":"Picazo","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.semerg.2014.06.012_bib0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1378\/chest.129.5.1219","article-title":"Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia","volume":"129","author":"De Roux","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.semerg.2014.06.012_bib0080","unstructured":"Polverino E, Rodriguez-Creixems M, Grau I, Molinos L, Rajas O, Llinares P, et al. Clinical presentations of invasive pneumococcal disease and associated comorbidities in adults in Spain. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2012. London, UK, 31 March-3 April 2012."},{"key":"10.1016\/j.semerg.2014.06.012_bib0085","unstructured":"Committee for Medicinal Products for Human Use (CHMP). European Medicines Agency (EMA). Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed). May 30, 2013. [consultado 15 Jul 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion\/human\/001104\/WC5.00143813.pdf"},{"key":"10.1016\/j.semerg.2014.06.012_bib0090","unstructured":"European Medicines Agency (EMA). Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed). Variation on marketing authorisation. EMEA\/H\/C\/1104\/II\/0071. July 9, 2013 [consultado 15 Jul 2013]. Disponible en: http:\/\/ec.europa.eu\/health\/documents\/communityregister\/html\/h590.htm"},{"key":"10.1016\/j.semerg.2014.06.012_bib0095","series-title":"Vacunas","first-page":"545","article-title":"Vacunaci\u00f3n antineumoc\u00f3cica de polisac\u00e1ridos capsulares","author":"Fedson","year":"2004"},{"key":"10.1016\/j.semerg.2014.06.012_bib0100","series-title":"Epidemiology and prevention of vaccine-preventable diseases","year":"2012"},{"key":"10.1016\/j.semerg.2014.06.012_bib0105","series-title":"La enfermedad neumoc\u00f3cica y su prevenci\u00f3n. Caminando hacia el futuro","first-page":"1","article-title":"Bacteriolog\u00eda del neumococo","author":"Eiros","year":"2010"},{"key":"10.1016\/j.semerg.2014.06.012_bib0110","series-title":"Vacunas","first-page":"605","article-title":"Vacunas antineumoc\u00f3cicas conjugadas","author":"Eskola","year":"2004"},{"key":"10.1016\/j.semerg.2014.06.012_bib0115","unstructured":"WHO. Acute respiratory infections: Streptococcus pneumoniae (update September 2009). Disponible en: http:\/\/apps.who.int\/vaccine_research\/diseases\/ari\/en\/index3.html#vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0120","unstructured":"Informe ENI (enfermedad neumoc\u00f3cica invasora). Comunidad Valenciana 2010. Disponible en: Servicio de Epidemiolog\u00eda y Vigilancia de la Salud. Direcci\u00f3n General de Salud P\u00fablica. Generalitat Valenciana. Enfermedad neumoc\u00f3cica invasora (ENI) Informes 2007 a 2011. [Internet]. Valencia: Generalitat Valenciana [acceso 2 Sep 2013]. Disponible en: http:\/\/www.sp.san.gva.es\/sscc\/opciones4.jsp?CodPunto=2903&Seccion=SANPCI1070205&ShowTitle=true&Opcion=SANMCI10702&MenuSup=SANMCI107&Nivel=2&perfil=ciud"},{"key":"10.1016\/j.semerg.2014.06.012_bib0125","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"Van der Poll","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2014.06.012_bib0130","first-page":"81","article-title":"Vigilancia de las infecciones invasivas notificadas al Sistema de Informaci\u00f3n Microbiol\u00f3gica en Espa\u00f1a. A\u00f1os 1993 a 1998","volume":"7","year":"1999","journal-title":"Bol Epidemiol Semanal"},{"key":"10.1016\/j.semerg.2014.06.012_bib0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2458-8-222","article-title":"The burden of community-acquired pneumonia in the elderly: The Spanish EVAN-65 study","volume":"8","author":"Ochoa-Gondar","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.semerg.2014.06.012_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2010.11.025","article-title":"The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)","volume":"29","author":"Gil-Prieto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2334-12-283","article-title":"Retrospective epidemiological study for the characterization of community-acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)","volume":"12","author":"Sicras-Mainar","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.semerg.2014.06.012_bib0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.semerg.2014.06.012_bib0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.eimc.2010.09.014","article-title":"Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine","volume":"29","author":"Payeras","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.semerg.2014.06.012_bib0160","first-page":"740","article-title":"Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality","volume":"29","author":"Guti\u00e9rrez Rodr\u00edguez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0165","unstructured":"Cill\u00f3niz C, Bouza E, Grau I, Molinos L, Salavert M, Llinares P et al. Influence of comorbidities in the clinical presentations of Invasive Pneumococcal Disease (IPD) in adults in Spain, 2010-2013. The ODIN study. Datos pendientes de publicaci\u00f3n."},{"key":"10.1016\/j.semerg.2014.06.012_bib0170","unstructured":"Recomendaciones SEMERGEN. Vacunaci\u00f3n en el adulto. 2013 [consultado Feb 2014]. Disponible en: http:\/\/www.ics.gentac.cat\/3clips\/main.php?page=AltresWebsPage"},{"key":"10.1016\/j.semerg.2014.06.012_bib0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.1996.03530270034028","article-title":"Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group","volume":"275","author":"Plouffe","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.semerg.2014.06.012_bib0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00006454-198601000-00009","article-title":"First and second dose antibody responses to neumococcal polysaccharide vaccine in infants","volume":"5","author":"Koskela","year":"1986","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.semerg.2014.06.012_bib0185","unstructured":"The National Network for Immunization Information. Vacuna antineumoc\u00f3cica conjugada 13 valente. Disponible en: Vacuna Antineumoc\u00f3cica Conjugada 13 Valente. The National Network for Immunization Information. (\u00daltimo acceso febrero de 2014) Disponible en: http:\/\/www.immunizationinfo.org\/node\/19503"},{"key":"10.1016\/j.semerg.2014.06.012_bib0190","unstructured":"Salud Madrid. Portal de Salud de la Comunidad de Madrid. Calendario de vacunaci\u00f3n para adultos [consultado 15 Jul 2013]. Disponible en: http:\/\/www.madrid.org\/cs\/Satellite?cid=1142427371738&language=es&pagename=PortalSalud%2FPage%2FPTSA_pintarContenidoFinal&vest=1156329829913"},{"key":"10.1016\/j.semerg.2014.06.012_bib0195","doi-asserted-by":"crossref","first-page":"223.e1","DOI":"10.1016\/j.medcli.2012.09.034","article-title":"Gu\u00eda multidisciplinar para la valoraci\u00f3n pron\u00f3stica, diagn\u00f3stico y tratamiento de la neumon\u00eda adquirida en la comunidad","volume":"140","author":"Torres","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.semerg.2014.06.012_bib0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jama.281.3.243","article-title":"Safety of revaccination with pneumococcal polysaccharide vaccine","volume":"281","author":"Jackson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.semerg.2014.06.012_bib0205","unstructured":"Sociedad Espa\u00f1ola de Medicina Preventiva, Salud P\u00fablica e Higiene. Recomendaciones de vacunaci\u00f3n antineumoc\u00f3cica en el adulto por indicaci\u00f3n m\u00e9dica. Revista de Medicina Preventiva. 2012;XVIII:1-33. [consultado 15 Jul 2013]. Disponible en: http:\/\/www.sempsph.com\/images\/stories\/recursos\/pdf\/protocolos\/2012\/Recom_VacAntineumococica_SEMPSPH.pdf"},{"key":"10.1016\/j.semerg.2014.06.012_bib0210","first-page":"101","article-title":"23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: Is it really effective?","volume":"53","author":"Cadeddu","year":"2012","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.semerg.2014.06.012_bib0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1473-3099(08)70239-1","article-title":"Pneumococcal polysaccharide vaccine effectiveness: Study quality must not be ignored","volume":"8","author":"Trotter","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.semerg.2014.06.012_bib0220","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semerg.2014.06.012_bib0225","unstructured":"Bouza E, Grau I, Torres A. Clinical presentations and serotypes causing community-adquired, healthcare-associated or nosocomial invasive pneumococcal disease in adults in a multicenter clinical surveillance in Spain (2010-2012). 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Berlin, Germany, April, 27-30, 2013."},{"key":"10.1016\/j.semerg.2014.06.012_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001390.pub3","article-title":"Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease","volume":"11","author":"Walters","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semerg.2014.06.012_bib0235","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0240","unstructured":"Ficha t\u00e9cnica Prevenar 13\u00ae [actualizado 19 Feb 2014]. Diponible en: Ficha t\u00e9cnica Prevenar 13. \u00daltima actualizaci\u00f3n 19\/02\/2014 [\u00faltimo acceso Mar 2014). Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR__Product_Information\/human\/001104\/WC500057247.pdf"},{"key":"10.1016\/j.semerg.2014.06.012_bib0245","series-title":"Epidemiology and prevention of vaccine-preventable diseases","first-page":"233","article-title":"Pneumococcal disease","year":"2011"},{"key":"10.1016\/j.semerg.2014.06.012_bib0250","unstructured":"Rodriguez-Creixems M, Pallares R, Torres A. Clinical presentations and serotypes causing invasive pneumococcal disease in immunocompromised vs. immunocompetent adults in a multicenter clinical surveillance in Spain (2010-2012). 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Berlin, Germany, April 27-30, 2013."},{"key":"10.1016\/j.semerg.2014.06.012_bib0255","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0265","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cir003","article-title":"A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults","volume":"52","author":"Lazarus","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semerg.2014.06.012_bib0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.semerg.2014.06.012_bib0270","unstructured":"Picazo J, Ruiz Contreras J, Casado J. Universal vaccination with PCV7 vs. VNC13: Changes in invasive pneumococcal disease incidence rates by clinical presentation and children age. 31st Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2013). Milan, Italy, May 8-June 1, 2013."},{"key":"10.1016\/j.semerg.2014.06.012_bib0275","unstructured":"Moore M, Link-Gelles R, Farley M, Thomas A, Reingold A, Harrsion L, et al. Early impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children<2 years old, U. S, 2010. 51st Interscience Conference on Antimicrobial Agents and Quemotherapy (ICAAC). Chicago, EE. UU., September, 17-20, 2011."},{"key":"10.1016\/j.semerg.2014.06.012_bib0280","first-page":"577","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0285","first-page":"594","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0290","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cis359","article-title":"Pneumococcal conjugate vaccine for adults: A new paradigm","volume":"55","author":"Paradiso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semerg.2014.06.012_bib0295","first-page":"585","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0300","unstructured":"Public Health England. Pneumococcal vaccination recommendations. Who should be vaccinated? [consultado 18 Feb 2014]. Disponible en: http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Pneumococcal\/GuidelinesPneumococcal\/pneumoRecommendations\/"},{"key":"10.1016\/j.semerg.2014.06.012_bib0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1183\/09031936.00126808","article-title":"Variability and effects of bronchial colonisation in patients with moderate COPD","volume":"35","author":"Marin","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semerg.2014.06.012_bib0310","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1128\/JCM.00767-12","article-title":"Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease","volume":"50","author":"Cabrera-Rubio","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.semerg.2014.06.012_bib0315","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","article-title":"Asthma as a risk factor for invasive pneumococcal disease","volume":"352","author":"Talbot","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2014.06.012_bib0320","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/thx.2009.132670","article-title":"Risk of invasive pneumococcal infections among working age adults with asthma","volume":"65","author":"Klemets","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.semerg.2014.06.012_bib0325","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.vaccine.2013.07.079","article-title":"Risk of invasive pneumococcal disease in children and adults with asthma: A systematic review","volume":"31","author":"Boikos","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0330","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2008.102681","article-title":"Suppression of pulmonary innate host defence in smokers","volume":"64","author":"Herr","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.semerg.2014.06.012_bib0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1378\/chest.83.1.23","article-title":"Pneumococcal adherence to the buccal epithelial cells of cigarette smokers","volume":"83","author":"Raman","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.semerg.2014.06.012_bib0340","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thx.49.8.825","article-title":"Effects of cigarette smoke on epithelial cells of the respiratory tract","volume":"49","author":"Dye","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.semerg.2014.06.012_bib0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0090-1229(91)90017-5","article-title":"The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men","volume":"59","author":"Mili","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.semerg.2014.06.012_bib0350","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/26.2.420","article-title":"Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population","volume":"26","author":"Sankilampi","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.semerg.2014.06.012_bib0355","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease","volume":"342","author":"Nuorti","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2014.06.012_bib0360","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1183\/09031936.00095807","article-title":"New evidence of risk factors for community acquired pneumonia: A population-based study","volume":"31","author":"Almirall","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semerg.2014.06.012_bib0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/thx.2009.123612","article-title":"Pneumococcal pneumonia presenting with septic shock: Host- and pathogen-related factors and outcomes","volume":"65","author":"Garcia-Vidal","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.semerg.2014.06.012_bib0370","first-page":"174","article-title":"Recomendaciones para la vacunaci\u00f3n neumoc\u00f3cica en fumadores","volume":"14","author":"Jim\u00e9nez Ruiz","year":"2012","journal-title":"Prev Tab"},{"key":"10.1016\/j.semerg.2014.06.012_bib0375","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/1469-0691.12182","article-title":"Invasive pneumococcal disease in patients with an underlying pulmonary disorder","volume":"19","author":"Inghammar","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semerg.2014.06.012_bib0380","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200310-1436ST","article-title":"Diagnosis and initial management of nonmalignant diseases related to asbestos","volume":"170","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semerg.2014.06.012_bib0385","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1017\/S0950268811002810","article-title":"Lung and pleural fibrosis in asbestos-exposed workers: A risk factor for pneumonia mortality","volume":"140","author":"Vehmas","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.semerg.2014.06.012_bib0390","first-page":"CD008865","article-title":"Pneumococcal vaccines for cystic fibrosis","volume":"9","author":"Burgess","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semerg.2014.06.012_bib0395","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.vaccine.2008.05.037","article-title":"Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease","volume":"26","author":"Furumoto","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2014.06.012_bib0400","first-page":"CD006316","article-title":"Pneumococcal vaccines for children and adults with bronchiectasis","volume":"2","author":"Chang","year":"2009","journal-title":"Cochrane Database Syst Rev"}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359314002949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359314002949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T04:28:21Z","timestamp":1538368101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359314002949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1138359314002949"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2014.06.012","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaci\u00f3n de la vacuna antineumoc\u00f3cica en las enfermedades respiratorias cr\u00f3nicas","name":"articletitle","label":"Article Title"},{"value":"SEMERGEN - Medicina de Familia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}